Supercharging Immune Cells May Help Control HIV Long-Term

Event overview

A revolutionary cancer treatment could transform autoimmune disease

Updated 2 days ago
Ars Technica
Wired
2 articles2 sources
Summary

Researchers are testing CAR T cell therapy as a way to reset the immune system. This cluster currently includes 2 articles from 2 sources.

What this means

This cluster currently includes 2 articles from 2 sources. Sources in this event include Wired, Ars Technica.

Original reporting (2)
A revolutionary cancer treatment could transform autoimmune disease
Ars Technica
Ars Technica
Leaning left
5/17/2026

A revolutionary cancer treatment could transform autoimmune disease

At age 49, Jan Janisch-Hanzlik’s multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a desk role. Frequent falls made her afraid to carry her grandchildren. She had to move to a bigger house to make room for the wheelchair she feared she might end up.

Supercharging Immune Cells May Help Control HIV Long-Term
Wired
Wired
Leaning left
5/18/2026

Supercharging Immune Cells May Help Control HIV Long-Term

A Miracle cancer therapy that involves engineering a patient’s own immune cells is being repurposed for HIV, and early results from two individuals hint at its promise for long-term control of the virus. As part of a clinical trial, scientists took people’s own immune cells and reprogrammed them in a lab to recognize.